Eric Bareke

7PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsNanomedicineGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.

Juliet Guay, Hellen Kuasne, Catherine Chabot

|Dec 11, 2025
H3K36 Methylation as a Guardian of Epigenome Integrity.

Reinnier Padilla, Gerry A Shipman, Cynthia Horth

|Aug 06, 2025
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.

Jinho Jeong, Simone Hausmann, Hanyang Dong

|Apr 09, 2022
H3K36 dimethylation shapes the epigenetic interaction landscape by directing repressive chromatin modifications in embryonic stem cells.

Haifen Chen, Bo Hu, Cynthia Horth

|Feb 03, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.

Marco Biondini, Alex Kiepas, Leeanna El-Houjeiri

|Dec 08, 2020
Whole-exome sequencing reveals novel vacuolar ATPase genes' variants and variants in genes involved in lysosomal biology and autophagosomal formation in oral granular cell tumors.

Josiane Alves França, Tenzin Gayden, Eric Bareke

Pageof 2

Frequent Collaborators

5 joint publications

Jacek Majewski

2 joint publications

Carolina Cavalieri Gomes

2 joint publications

Tenzin Gayden

2 joint publications

Gerry A Shipman